| Condition | Expected urine osmolality | Expected urine sodium | Expected volume status | Why it does not fit this patient |
|---|---|---|---|---|
| SIADH | High, inappropriately concentrated | Usually >40 mEq/L | Euvolemic or mildly hypervolemic | Matches all findings |
| Hypovolemic hyponatremia from poor oral intake | High as an appropriate ADH response to volume loss | Low, usually
임상 시나리오SIADH in Small Cell Lung CancerEuvolemic Hyponatremia Recognition and Management The diagnostic triad for SIADH is low serum osmolality (258 mOsm/kg), inappropriately concentrated urine (640 mOsm/kg), and elevated urine sodium (45 mEq/L) in a clinically euvolemic patient. Small cell lung cancer is the most common malignancy causing paraneoplastic SIADH. Tumor cells secrete ADH or ADH-like peptides independent of normal osmoregulation, leading to free water retention without sodium deficit. Volume status is the key discriminator. Normal skin turgor, no edema, and stable blood pressure without orthostatic change confirm euvolemia, ruling out hypovolemic and hypervolemic causes. Caution Correct serum sodium slowly in SIADH. Rapid correction beyond 8-10 mEq/L per 24 hours risks osmotic demyelination syndrome. Fluid restriction is first-line, with vasopressin receptor antagonists reserved for refractory cases. 핵심 개념
PNLE Question Bank 1500
1,500 문제 · 로그인 없이 바로 볼 수 있어요
학습 참고용입니다. 실제 임상은 최신 지침과 소속 기관 프로토콜을 따르세요. |